Analysis | Metabolite Name | Measured Value | Units | diabetes | time of day |
---|---|---|---|---|---|
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.6718 | VolNormImp Area counts | db/db | ZT17 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.9299 | VolNormImp Area counts | db/db | ZT17 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.9301 | VolNormImp Area counts | db/db | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.023 | VolNormImp Area counts | db/m | ZT17 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.1045 | VolNormImp Area counts | db/m | ZT17 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.1234 | VolNormImp Area counts | db/m | ZT17 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.2424 | VolNormImp Area counts | db/m | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.3933 | VolNormImp Area counts | db/db | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.5107 | VolNormImp Area counts | db/m | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.541 | VolNormImp Area counts | db/db | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.5828 | VolNormImp Area counts | db/m | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.5835 | VolNormImp Area counts | db/db | ZT17 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.8117 | VolNormImp Area counts | db/m | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 2.2226 | VolNormImp Area counts | db/m | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 2.3757 | VolNormImp Area counts | db/db | ZT5 |